ID

30607

Descripción

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00930475

Link

https://clinicaltrials.gov/show/NCT00930475

Palabras clave

Versiones (1)
  1. 17/6/18 17/6/18 -
Titular de derechos de autor

see clinicaltrials.gov

Subido en

17 de junio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00930475

Inglés

Eligibility Breast Cancer NCT00930475

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult female patients
Descripción

Gender; Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
at least two prior chemotherapies due to metastatic or inoperable breast cancer
Descripción

Prior Chemotherapy Due to Carcinoma breast stage IV; Prior Chemotherapy Due to Breast Carcinoma, Inoperable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0278488
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0678222
UMLS CUI [2,4]
C0205187
karnofsky performance status of at least 60%
Descripción

Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
pretreatment with at least one taxane and one anthracycline
Descripción

Pretreatment taxane; Pretreatment Anthracyclines

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3539076
UMLS CUI [1,2]
C0215136
UMLS CUI [2,1]
C3539076
UMLS CUI [2,2]
C0282564
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with mtor-inhibitors, carboplatin, cisplatin or oxaliplatin
Descripción

mTOR Inhibitor, Therapeutic procedure, Previous; Carboplatin, Therapeutic procedure, Previous; Cisplatin, Therapeutic procedure, Previous; oxaliplatin, Therapeutic procedure, Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2746052
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C0079083
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0205156
UMLS CUI [3,1]
C0008838
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C0205156
UMLS CUI [4,1]
C0069717
UMLS CUI [4,2]
C0087111
UMLS CUI [4,3]
C0205156
inadequate organ function including bone marrow function
Descripción

body system or organ function, Inadequate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205412
bleeding tumours
Descripción

Malignant Neoplasms, Hemorrhage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0019080
known uncontrolled metastases in cns or carcinomatous meningosis
Descripción

CNS metastases, Uncontrolled; Meningeal Carcinomatosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0220654
patients who have been treated during the last five days with inhibitors or inducers of cyp3a
Descripción

Cytochrome P450 3A4 Inhibitor, Therapeutic procedure, Previous; Cytochrome P450 3A4 Inducer, Therapeutic procedure, Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3830624
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C3830625
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0205156
serious pulmonary, neurological, endocrinological or other disorders interfering with this study medication, especially patients with known lung fibrosis, emphysema or severe copd
Descripción

Bronchopulmonary disease, Serious, Interferes with clinical trial drug; nervous system disorder, Serious, Interferes with, clinical trial drug; Endocrine System Diseases, Serious, Interferes with clinical trial drug; Disease, Other, Interferes with clinical trial drug

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1096000
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C3854006
UMLS CUI [2,1]
C0027765
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C3854006
UMLS CUI [3,1]
C0014130
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0521102
UMLS CUI [3,4]
C3854006
UMLS CUI [4,1]
C0012634
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0521102
UMLS CUI [4,4]
C3854006
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00930475

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender; Age
Item
adult female patients
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Prior Chemotherapy Due to Carcinoma breast stage IV; Prior Chemotherapy Due to Breast Carcinoma, Inoperable
Item
at least two prior chemotherapies due to metastatic or inoperable breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,3])
C1514457 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C0205187 (UMLS CUI [2,4])
Karnofsky Performance Status
Item
karnofsky performance status of at least 60%
boolean
C0206065 (UMLS CUI [1])
Pretreatment taxane; Pretreatment Anthracyclines
Item
pretreatment with at least one taxane and one anthracycline
boolean
C3539076 (UMLS CUI [1,1])
C0215136 (UMLS CUI [1,2])
C3539076 (UMLS CUI [2,1])
C0282564 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
mTOR Inhibitor, Therapeutic procedure, Previous; Carboplatin, Therapeutic procedure, Previous; Cisplatin, Therapeutic procedure, Previous; oxaliplatin, Therapeutic procedure, Previous
Item
previous treatment with mtor-inhibitors, carboplatin, cisplatin or oxaliplatin
boolean
C2746052 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0079083 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
C0008838 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
C0069717 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0205156 (UMLS CUI [4,3])
body system or organ function, Inadequate
Item
inadequate organ function including bone marrow function
boolean
C0678852 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
Malignant Neoplasms, Hemorrhage
Item
bleeding tumours
boolean
C0006826 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
CNS metastases, Uncontrolled; Meningeal Carcinomatosis
Item
known uncontrolled metastases in cns or carcinomatous meningosis
boolean
C0686377 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0220654 (UMLS CUI [2])
Cytochrome P450 3A4 Inhibitor, Therapeutic procedure, Previous; Cytochrome P450 3A4 Inducer, Therapeutic procedure, Previous
Item
patients who have been treated during the last five days with inhibitors or inducers of cyp3a
boolean
C3830624 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C3830625 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
Bronchopulmonary disease, Serious, Interferes with clinical trial drug; nervous system disorder, Serious, Interferes with, clinical trial drug; Endocrine System Diseases, Serious, Interferes with clinical trial drug; Disease, Other, Interferes with clinical trial drug
Item
serious pulmonary, neurological, endocrinological or other disorders interfering with this study medication, especially patients with known lung fibrosis, emphysema or severe copd
boolean
C1096000 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C3854006 (UMLS CUI [1,4])
C0027765 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C3854006 (UMLS CUI [2,4])
C0014130 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0521102 (UMLS CUI [3,3])
C3854006 (UMLS CUI [3,4])
C0012634 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0521102 (UMLS CUI [4,3])
C3854006 (UMLS CUI [4,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial